Effects of Salicylate Administration on Metabolic Activity in the Rat Auditory Center / 听力学及言语疾病杂志

Objective To investigate the neural activity in the central auditory pathway by using a tinnitus an-imal model .Methods Twenty -four rats were randomly divided into the control ,acute salicylate treatment ,chronic salicylate treatment ,and recovery groups .The gap prepulse inhibition of acoustic startle test was used to confirm tinnitus -like behavior .After delivery of an intravenous bolus of fluorine -18 fluorodeoxyglucose (18F -FDG ) , small animal positron emission tomography scans were performed on rats .Results Only rats in chronic salicylate -treatment group showed evidence of experiencing tinnitus .The SUV ratios of the AC were significantly greater in the acute salicylate treatment group than in the control group (P<0 .01) ,suggesting relatively increased metabolism in the two brain regions of the rats in this group .The SUV ratios of the IC and AC (P<0 .01) ,but not of the CRB (P>0 .05) were greater in the chronic salicylate treatment group than in the control groups .There was a significant difference in whole brain SUVs between the control and acute salicylate treatment groups (P<0 .01) ,the whole brain SUVs in chronic salicylate treatment group were a little higher but showed no significant difference (P>0 .05) .There was no significant difference in the SUVs between the control and recovery groups (P>0 .05) .Conclu-sion These findings indicate that long -term salicylate administration induced tinnitus in rats and may have en-hanced neural activity corresponded to the up -regulated metabolic rate in our study .Alterations to neuroplasticity of the CNS may lead to tinnitus .

Enhanced Efficacy of Human Brain-Derived Neural Stem Cells by Transplantation of Cell Aggregates in a Rat Model of Parkinson's Disease

OBJECTIVE: Neural tissue transplantation has been a promising strategy for the treatment of Parkinson's disease (PD). However, transplantation has the disadvantages of low-cell survival and/or development of dyskinesia. Transplantation of cell aggregates has the potential to overcome these problems, because the cells can extend their axons into the host brain and establish synaptic connections with host neurons. In this present study, aggregates of human brain-derived neural stem cells (HB-NSC) were transplanted into a PD animal model and compared to previous report on transplantation of single-cell suspensions. METHODS: Rats received an injection of 6-OHDA into the right medial forebrain bundle to generate the PD model and followed by injections of PBS only, or HB-NSC aggregates in PBS into the ipsilateral striatum. Behavioral tests, multitracer (2-deoxy-2-[18F]-fluoro-D-glucose ([18F]-FDG) and [18F]-N-(3-fluoropropyl)-2-carbomethoxy-3-(4-iodophenyl)nortropane ([18F]-FP-CIT) microPET scans, as well as immunohistochemical (IHC) and immunofluorescent (IF) staining were conducted to evaluate the results. RESULTS: The stepping test showed significant improvement of contralateral forelimb control in the HB-NSC group from 6-10 weeks compared to the control group (p<0.05). [18F]-FP-CIT microPET at 10 weeks posttransplantation demonstrated a significant increase in uptake in the HB-NSC group compared to pretransplantation (p<0.05). In IHC and IF staining, tyrosine hydroxylase and human beta2 microglobulin (a human cell marker) positive cells were visualized at the transplant site. CONCLUSION: These results suggest that the HB-NSC aggregates can survive in the striatum and exert therapeutic effects in a PD model by secreting dopamine.

MicroSPECT and MicroPET Imaging of Small Animals for Drug Development

The process of drug discovery and development requires substantial resources and time. The drug industry has tried to reduce costs by conducting appropriate animal studies together with molecular biological and genetic analyses. Basic science research has been limited to in vitro studies of cellular processes and ex vivo tissue examination using suitable animal models of disease. However, in the past two decades new technologies have been developed that permit the imaging of live animals using radiotracer emission, X-rays, magnetic resonance signals, fluorescence, and bioluminescence. The main objective of this review is to provide an overview of small animal molecular imaging, with a focus on nuclear imaging (single photon emission computed tomography and positron emission tomography). These technologies permit visualization of toxicodynamics as well as toxicity to specific organs by directly monitoring drug accumulation and assessing physiological and/or molecular alterations. Nuclear imaging technology has great potential for improving the efficiency of the drug development process.

Investigación preclínica por microPET en la UNAM / Pre-clinical research at UNAM using microPET

La tomografía por emisión de positrones (PET) es una técnica de imágenes de medicina nuclear ya establecida en México, fundamental en el diagnóstico y seguimiento clínico de enfermedades oncológicas, neurológicas y cardiológicas. Esta modalidad de imagenología molecular está basada en la administración de cantidades muy pequeñas de fármacos marcados con emisores de positrones y en la subsecuente detección de radiación con el fin de obtener imágenes tomográficas que reflejan la distribución del radiofármaco en el paciente. El desarrollo de nuevos radiofármacos para PET requiere de un método para verificar que éstos siguen las rutas metabólicas de interés, que su vida media biológica es suficiente para la realización de un estudio, que no tienen efectos adversos y que es viable para estudios en pacientes. El desarrollo de equipos de microtomografía por emisión de positrones (microPET), dedicados a estudiar animales de laboratorio, ha permitido realizar estas pruebas antes de su aplicación clínica. Además, el microPET es una herramienta de gran utilidad en la investigación preclínica de diversas enfermedades, en el desarrollo de tratamientos innovadores que permite el seguimiento no invasivo en modelos animales. En la Unidad PET/CT-Ciclotrón de la Facultad de Medicina de la UNAM, se cuenta desde hace unos años con un equipo microPET para investigación. En este trabajo se muestran algunos resultados de los estudios que se realizan con mayor frecuencia con el microPET utilizando los radiofármacos de mayor uso en el medio clínico y se muestra la utilidad que puede tener en diversos proyectos de investigación.

Positron emission tomography (PET) is a nuclear medicine imaging technique well established in Mexico, essential for the clinical diagnosis and follow-up of oncological, neurological and cardiac pathologies. This molecular imaging modality is based on the administration of small amounts of drugs labeled with a positron emitting radionuclides and the subsequent radiation detection to obtain tomographic images which reflect the distribution of the radiopharmaceutical in the patient. The development of new radiopharmaceuticals for PET requires a method to verify that they follow the expected metabolic pathways, that they have a long-enough biological half-life for imaging studies, that they have no side effects and that it is viable for use in patients. The development of positron emission microtomography (microPET) systems to be used in small laboratory animale has allowed researchers to perform these tests on radiopharmaceuticals before being used in the clinic. In addition, microPET is a useful tool in preclinical research of different diseases in the development of innovating non-invasive treatments allowing to follow up animal models. At the PET/CT-Ciclotron Unit, Facultad de Medicina, UNAM, a microPET system has been available in the last few years for research purposes. In this work, examples of frequent imaging studies performed with the microPET and in-the-clinic commonly-used radiopharmaceuticals, as well the use it may have in different research projects are shown here.

Central Nervous System Drug Evaluation Using Positron Emission Tomography

In conventional pharmacological research in the field of mental disorders, pharmacological effect and dose have been estimated by ethological approach and in vitro data of affinity to the site of action. In addition, the frequency of administration has been estimated from drug kinetics in blood. However, there is a problem regarding an objective index of drug effects in the living body. Furthermore, the possibility that the concentration of drug in blood does not necessarily reflect the drug kinetics in target organs has been pointed out. Positron emission tomography (PET) techniques have made progress for more than 20 years, and made it possible to measure the distribution and kinetics of small molecule components in living brain. In this article, we focused on rational drug dosing using receptor occupancy and proof-of-concept of drugs in the drug development process using PET.

Modelo de evaluación de metabolismo y perfusión en el miocardio de rata mediante 18F-FDG, 1-11C-acetato, 13N-amoniaco y micro-tomografía por emisión de positrones (micro PET) / Cardiac metabolism and perfusion evaluation in a rat model using 18F-FDG,1- 11C-acetate, 13NH3 and micro-positron emission tomography (microPET)

Objetivos: Estandarizar un protocolo de adquisición para el estudio del metabolismo glucolítico, oxidativo y de perfusión miocárdicos en un modelo de rata. Métodos: Se realizaron estudios con los tres principales radiotrazadores usados para evaluar la función cardiaca: 18F-FDG para evaluar el metabolismo glucolítico en tres protocolos distintos; 1-11C-acetato para el metabolismo oxidativo y 13NH3 para la perfusión cardiaca. (18F-FDG)- cinco ratas Wistar macho en tres diferentes protocolos: con acceso a libre demanda de comida y agua; con ayuno de ocho horas y con ayuno de ocho horas más carga oral de glucosa al 50%. Se adquirieron imágenes del área torácica durante 30 minutos mediante microPET; 30 y 60 minutos post-administración de 370 - 555 MBq de 18F-FDG vía IP. (1-11C-acetato)- Se estudiaron ocho ratas. Cuatro estudios estáticos de 30 minutos y cuatro adquisiciones dinámicas de 30 minutos tras administración de 370 - 555 MBq de1-11C-acetato por vena caudal.(13NH3)- 10 estudios estáticos de 15 minutos después de una dosis IV de 370 - 555 MBq de 13NH3, bajo anestesia inhalada con isofluorano a 1.5% a 2%. Se realizó análisis comparativo y cualitativo de todas las imágenes obtenidas por dos médicos especialistas en el área y un análisis semi-cuantitativo mediante reconstrucciones 3D y selección de ROIs con el programa AMIDE en el caso de 18F-FDG. Resultados: Se determinó que las mejores imágenes para fines de evaluación metabólica del miocardio fueron las correspondientes a los 60 minutos post-administración de la 18F-FDG del protocolo sin ayuno. Se visualizó sin problemas el miocardio de rata de las imágenes estáticas con 1-11C-acetato, y mediante adquisición dinámica, se pudo apreciar la perfusión miocárdica. Las imágenes con 13NH3 permitieron observar una distribución homogénea del radiotrazador en los diferentes segmentos del ventrículo izquierdo en el eje corto, eje largo vertical y eje largo horizontal. Conclusiones: Se logró la estandarización de protocolos de adquisición de imágenes de los tres principales radiotrazadores utilizados para el estudio del metabolismo y perfusión cardiacos, en un modelo animal. Es factible establecer un protocolo válido para la valoración de perfusión, metabolismo glucolítico y oxidativo miocárdicos, con el fin de utilizarlo como punto de referencia para la evaluación de terapias génica, farmacológica o quirúrgica a nivel experimental.

Objective: To standardize an acquisition protocol for the study of myocardial glucolitic and oxidative metabolism and perfusion in a rat model. Methods: Studies were carried out with the three main radiopharmaceuticals used to assess heart function:[18F]-FDG for glucolitic metabolism; [1-11C]-acetate for oxidative metabolism and [13N]-NH3for myocardial perfusion.[18F]-FDG -Five Wistar adult male rats were studied in three different protocols: non-fasting group, fasting group,8 h before the study with water provided ad libitum, and a fasting group by the same time receiving an oral 50%-glucose solution. Thirty-minute scans were performed with a microPET Focus 120, 30 and 60 min after the administration of 370-555 MBq 18F-FDG. [1-11C]-Acetate -Eight rats were studied. Four static and four dynamic 30 min acquisitions after a 370-555 MBq of [1-11C]-acetate caudal vein administration.[13N]-NH3-Ten static studies were acquired 15 min post-administration of 370555 MBqof13NH3, under 1.5-2% isofluorane anesthesia. Comparative and visual analyses were performed by two experts in the field. A semi-quantitative analysis was performed using 3D reconstructions and ROI selections with AMIDE software. Results: The best images were those obtained from the non-fasting group, especially those taken at 60 min after the [18F]-FDG administration. High quality myocardial, static images were obtained with [1-11C]-acetate, and the dynamic acquisitions allowed the identification of myocardial perfusion. The 13NH3images showed a homogeneous distribution of the radiotracer in different segments of the short, long and horizontal axes in the left ventricle. Conclusions: It is possible to standardize the microPET acquisition protocols for the three main radiopharmaceuticals to evaluate the heart function in a rat model. It is feasible to establish a valid protocol for measuring glucolitic and oxidative myocardial metabolism and perfusion for gene, drug or surgical therapy assessment.

Noninvasive observation of atherosclerosis in mice with 7.0T MR and Micro-PET / 中国医学影像技术

Objective To explore the feasibility of detecting atherosclerosis with 7.0T MR and Micro-PET. Methods Ten 46-week-old ApoE-/- mice with high lipid diet for 6 months were selected to establish atherosclerosis models. Among them, 5 mice underwent MRI before and 12 h, 24 h, 36 h after injection of SPIO, respectively, and the other 5 mice were injected with ~(18)F-fluorodeoxyglucose (~(18)F-FDG) through tail vein and observed with Micro-PET after 1 h, 2 h and 3 h. The specimens of abdominal aorta were taken for pathologic examination. Results Atherosclerotic plaques were observed in all animals with 7.0T MRI after 6 months high lipid diet. Thirty-six hours after the injection of SPIO, the high signal rings were thinner and the lumen of blood vessels were wider than those before injection on T2WI. Radioactive concentration was observed in abdominal aorta and both sides of iliac artery 3 h after the injection of ~(18)F-fluorodeoxyglucose (~(18)F-FDG). Pathological examination showed the formation of atherosclerotic plaques and the aggregation of the macrophages. Conclusion 7.0T MRI and Micro-PET can be used to observe the macrophage-rich plaque and to judge the vulnerability of plaque, thus provide theoretical basis for early detection, diagnosis and treatment of atherosclerosis.

Performance Characteristics of MicroPET R4 Scanner for Small Animal Imaging / 대한핵의학회잡지

PURPOSE: Dedicated animal PET is useful equipment for the study of new PET tracer. Recently, microPET R4 was installed in the Korea institute of radiology and medical science. In this study, we measured the characteristics of scanner. MATERIALS AND METHODS: Resolution was measured using a line source (F-18: 65 micro Ci, inner diameter: 0.5 mm). The line source was put in the axial direction and was moved from the center of field of view to outside with 1 mm interval. PET images were reconstructed using a filtered back-projection and ordered subset expectation maximization. Line source (16.5 micro Ci, 78 mm) was put on the center of axial direction to measure the sensitivity when the deadtime was under 1%. Images were acquired during 4 minutes respectively from center to 39 mm outward. Delayed count was subtracted from total count and then decay was corrected for the calculation of sensitivity. Noise equivalent count ratio and scatter fraction were calculated using cylindrical phantom. RESULTS: Spatial resolution of reconstructed image using filtered back-projection was 1.86 mm (radial), 1.95 mm (tangential), 1.95 mm (axial) in the center of field of view, and 2.54 mm, 2.8 mm, 1.61 mm in 2 cm away from the center respectively. Sensitivity was 2.36% at the center of transaxial field of view. Scatter fraction was 20%. Maximal noise equivalent count ratio was 66.4 kcps at 242 kBq/mL. Small animal images were acquired for confirmation of performance. CONCLUSION: Performance characteristics of microPET R4 were similar with reported value. So this will be a useful tool for small animal imaging.

Evaluation of Cat Brain Infarction Model Using MicroPET / 대한핵의학회잡지

PURPOSE: PET has some disadvantage in the imaging of small animal due to poor resolution. With the advent of microPET scanner, it is possible to image small animals. However, the image quality was not good enough as human image. Due to larger brain, cat brain imaging was superior to mouse or rat. In this study, we established the cat brain infarction model and evaluate it and its temporal change using microPET scanner. MATERIALS AND METHODS: Two adult male cats were used. Anesthesia was done with xylazine and ketamine HCl. A burr hole was made at 1cm right lateral to the bregma. Collagenase type IV 10 microliter was injected using 30 G needle for 5 minutes to establish the infarction model. 18F-FDG microPET (Concorde Microsystems Inc., Knoxville, TN) scans were performed 1, 11 and 32 days after the infarction. In addition, 18F-FDG PET scans were performed using human PET scanner (Gemini, Philips medical systems, CA, USA) 13 and 47 days after the infarction. RESULTS: Two cat brain infarction models were established. The glucose metabolism of an infarction lesion improved with time. An infarction lesion was also distinguishable in the human PET scan. CONCLUSION: We successfully established the cat brain infarction model and evaluated the infarcted lesion and its temporal change using 18F-FDG microPET scanner.